Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Forchielli, M. L.
Right arrow Articles by Lo, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forchielli, M. L.
Right arrow Articles by Lo, C. W.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Antibiotics
*Bacterial Infections
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Success Rates and Cost-Effectiveness of Antibiotic Combinations for Initial Treatment of Central-Venous-Line Infections During Total Parenteral Nutrition

M. Luisa Forchielli, MD

Department of Pediatrics, University of Bologna, 1.forchielli{at}post.harvard.edu

Kathleen Gura, RPh

Departrnent of Pharmacy, Children's Hospital, Boston, Massachussets

Eugenio Anessi-Pessina, PHD

Department of Business Administration, The Catholic University, Milan, Italy

Denise Richardson, RN

Combined Program in Gastroenterology and Nutrition, Children's Hospital, Boston, Massachussets

Wei Cai, MD

Department of Pediatric Surgery, Xin Hua Hospital, University of Shanghai, China

Clifford W. Lo, MD

Combined Program in Gastroenterology and Nutrition, Children's Hospital, Boston, Massachussets

Background: Central-venous-line infections can be successfully treated with appropriate antibiotics, thus avoiding the need for catheter removal. Based on our experience, vancomycin, gentamicin, piperacillin, ceftazidime, and amphotericin, alone or in combination, are usually administered, pending sensitivity results. This empirical list, however, has never been verified against actual sensitivity results nor has it been tested for cost or efficacy. Methods: Medical records of inpatients on hyperalimentation over 1 year were reviewed. Success rate, therapy duration, and drug acquisition cost and charge were assessed for central-venous-line infections. Antibiotics then were paired and evaluated in terms of charge and efficacy against all microorganisms as determined by sensitivity results. Results: In 500 inpatients receiving hyperalimentation for 9698 patient-days, 8.4 central-venous-line infections/1000 patient-days occurred. Staphylococcus non-aureus , Candida species, Enterococcus faecium, and Staphylococcus aureus predominantly were isolated. Of the infections, 51 (67%) were sensitive to one or more of the initial antibiotics. A 2-week course of antibiotics successfully treated 50 (66%) catheter infections without line removal. Appropriate initial therapy on average reduced treatment duration by 8 to 10 days and drug charges by $400 to $700. Conclusions: Amikacin-vancomycin appears to be the most cost-effective selection for presumed central-venous-line infections, pending sensitivity results, followed by valid alternatives. Lower failure rates are well worth the extra cost in pharmaceutical charges. (Journal of Parenteral and Enteral Nutrition 24:119-125, 2000)

Journal of Parenteral and Enteral Nutrition, Vol. 24, No. 2, 119-125 (2000)
DOI: 10.1177/0148607100024002119


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
M.-Y. S. Moosa, J. D. Sobel, H. Elhalis, W. Du, and R. A. Akins
Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative Medium
Antimicrob. Agents Chemother., January 1, 2004; 48(1): 161 - 167.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. J. Wanten, M. G. Netea, T. H. Naber, J. H. Curfs, L. E. Jacobs, T. J. Verver-Jansen, and B.-J. Kullberg
Parenteral Administration of Medium- but Not Long-Chain Lipid Emulsions May Increase the Risk for Infections by Candida albicans
Infect. Immun., November 1, 2002; 70(11): 6471 - 6474.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
American Society for Parenteral and Enteral Nutrit
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
JPEN J Parenter Enteral Nutr, January 1, 2002; 26(1_suppl): 1SA - 138SA.
[PDF]